Cochlear Ltd

Common Name

Cochlear

Country

Australia

Sector

Healthcare

Industry

Medical Devices

Employees

5,500

Ticker

COH

Exchange

ASX

Website

www.cochlear.com

Description

Cochlear Ltd is a global leader in the medical technology sector, specializing in the development and manufacturing of implantable hearing solutions. The company’s primary products include cochlear im... Show more

Financial Statements of Cochlear

Below are the financial statements of Cochlear, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of AUD	2024 as of 2024-06-30	2023 as of 2023-06-30
Assets	—	—
Cash and cash equivalents	513.6^a	555.5^a
Trade and other receivables	490.7^a	437.5^a
Forward exchange contracts	7.7^a	3.7^a
Inventories	391.6^a	311.5^a
Current tax assets	11.3^a	20^a
Prepayments	37.2^a	33.3^a
Total current assets	1,452.1^a	1,361.5^a
Trade and other receivables	1.3^a	0.9^a
Forward exchange contracts	3.5^a	1.6^a
Property, plant and equipment	304.8^a	276.7^a
Intangible assets	451^a	444.1^a
Investments	80.5^a	93.8^a
Other financial assets	97.9^a	90.8^a
Equity-accounted investments	2.9^a	3.5^a
Deferred tax assets	138.7^a	125.3^a
Right of use assets	212.4^a	170.5^a
Total non-current assets	1,293^a	1,207.2^a
Total assets	2,745.1^a	2,568.7^a
Liabilities	—	—
Trade and other payables	303.2^a	270.4^a
Forward exchange contracts	8.5^a	20.6^a
Current tax liabilities	17.6^a	17.5^a
Employee benefit liabilities	150.5^a	146.4^a
Provisions	43.4^a	22.3^a
Deferred revenue	66.7^a	61.6^a
Lease liabilities	41.6^a	39.2^a
Total current liabilities	631.5^a	578^a
Forward exchange contracts	0.4^a	6.4^a
Employee benefit liabilities	7.8^a	9.7^a
Provisions	35.3^a	35.1^a
Deferred tax liabilities	18.9^a	18.3^a
Deferred revenue	8.6^a	9.8^a
Lease liabilities	202.1^a	162.6^a
Total non-current liabilities	273.1^a	241.9^a
Total liabilities	904.6^a	819.9^a
Net assets	1,840.5^a	1,748.8^a
Equity	—	—
Share capital	1,204.2^a	1,250.3^a
Reserves	-31.6^a	-56.9^a
Retained earnings	667.9^a	555.4^a
Total equity	1,840.5^a	1,748.8^a

Download Data

Verified Sources Behind Cochlear’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Cochlear’s data sources below and access millions more through our Disclosure Search.

a. Cochlear's Annual Report 2024

b. Cochlear's Annual Report 2025

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Cochlear Ltd

Financial Statements of Cochlear

Verified Sources Behind Cochlear’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Getinge AB

LivaNova PLC

Ambu A/S

GN Store Nord A/S

Penumbra Inc

Haemonetics Corp